Press Releases from DelveInsight Business Research LLP (4751 total)
Diabetic Neuropathy Market Expected to rise, 2034 | Novo Nordisk, Ionis Pharmace …
The Diabetic Neuropathy market growth is driven by factors like increase in the prevalence of Diabetic Neuropathy, investments in research and development, entry of emerging…
Chronic Lower Back Pain Market Expected to rise, 2034 | Eli Lilly and Company, C …
The Chronic Lower Back Pain market growth is driven by factors like increase in the prevalence of Chronic Lower Back Pain, investments in research and…
Chronic Obstructive Pulmonary Disease Market Expected to rise, 2034 | AstraZenec …
The Chronic Obstructive Pulmonary Disease market growth is driven by factors like increase in the prevalence of Chronic Obstructive Pulmonary Disease, investments in research and…
Periodontal Disease Market Expected to rise, 2032 | Dentsply Sirona Inc., Envist …
The Periodontal Disease market growth is driven by factors like increase in the prevalence of Periodontal Disease, investments in research and development, entry of emerging…
Medical Drones Market Set for Significant Growth Through 2032, Says DelveInsight
DelveInsight's Medical Drones Market Insights Report 2032 provides the current and forecast market analysis, individual leading Medical Drones Companies market shares, challenges, Medical Drones Market…
DelveInsight Predicts Robust Expansion of Clinical Trial Support Services Market …
DelveInsight's Clinical Trial Support Services Market Insights Report 2032 provides the current and forecast market analysis, individual leading Clinical Trial Support Services Companies market shares,…
Acquired Immunodeficiency Syndrome Market on Track for Major Expansion by 2032, …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as…
Genital Warts Pipeline Appears Robust With 30+ Key Pharma Companies Actively Wor …
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the…
Endometriosis Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring …
DelveInsight's, "Endometriosis Pipeline Insight 2025" report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in Endometriosis pipeline landscape. It covers the Endometriosis pipeline…
HPV16+ Cancer Pipeline Appears Robust With 10+ Key Pharma Companies Actively Wor …
DelveInsight's, "Human papillomavirus 16-positive (HPV16+) cancers Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Human papillomavirus 16-positive (HPV16+)…
ER+/ HER2 -ve Breast Cancer Pipeline Appears Robust With 20+ Key Pharma Companie …
DelveInsight's, "ER positive, HER2 negative Breast Cancer Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in ER positive, HER2…
Chronic Obstructive Pulmonary Disease Pipeline Appears Robust With 65+ Key Pharm …
DelveInsight's "Chronic Obstructive Pulmonary Disease Pipeline Insight 2025" report provides comprehensive insights about 65+ companies and 70+ pipeline drugs in the Chronic Obstructive Pulmonary Disease…
Bronchitis Pipeline Appears Robust With 15+ Key Pharma Companies Actively Workin …
DelveInsight's, "Bronchitis Pipeline Insight 2025" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Bronchitis pipeline landscape. It covers the Bronchitis Pipeline…
Asthma Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in …
DelveInsight's, "Asthma Pipeline Insight 2025" report provides comprehensive insights about 80+ companies and 90+ pipeline drugs in Asthma pipeline landscape. It covers the Asthma pipeline…
Non-Muscle Invasive Bladder Cancer Market: Epidemiology, Therapies, Companies, D …
Non-Muscle Invasive Bladder Cancer therapies are expected to boost the Non-Muscle Invasive Bladder Cancer Market in the upcoming years.
DelveInsight has launched a new report on…
Nontuberculous Mycobacterial Infections Market: Epidemiology, Therapies, Compani …
Nontuberculous Mycobacterial Infections therapies, such as ARIKAYCE (amikacin liposome inhalation suspension), Epetraborole, MNKD-101 (Clofazimine Inhalation Suspension), SPR720 (Fobrepodacin), and others, are expected to boost the…
Cough in Idiopathic Pulmonary Fibrosis Market: Epidemiology, Therapies, Companie …
Cough in Idiopathic Pulmonary Fibrosis therapies, such as Orvepitant Maleate, Haduvio (nalbuphine ER), and others, are expected to boost the Cough in Idiopathic Pulmonary Fibrosis…
Diamond Blackfan Anemia Market: Epidemiology, Therapies, Companies, DelveInsight …
Diamond Blackfan Anemia therapies are expected to boost the Diamond Blackfan Anemia Market in the upcoming years.
DelveInsight has launched a new report on "Diamond Blackfan…
Myelofibrosis Market: Epidemiology, Therapies, Companies, DelveInsight | Abbvie, …
Myelofibrosis therapies, such as JAKAFI/JAKAVI (ruxolitinib), INREBIC (fedratinib), XPOVIO (selinexor), RYTELO (imetelstat), REBLOZYL (luspatercept/ACE-536), and others, are expected to boost the Myelofibrosis Market in the…
Cholangiocarcinoma Clinical Trials Appears Robust With 55+ Key Pharma Companies …
DelveInsight's, "Cholangiocarcinoma Pipeline Insight 2025" report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Cholangiocarcinoma pipeline landscape. It covers the Cholangiocarcinoma Pipeline…
Diabetic Macular Edema Clinical Trials Appears Robust With 45+ Key Pharma Compan …
DelveInsight's, "Diabetic Macular Edema Pipeline Insight 2025" report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Diabetic Macular Edema pipeline landscape. It…
Crohn's Disease Clinical Trials Appears Robust With 90+ Key Pharma Companies Act …
DelveInsight's, "Crohn's Disease Pipeline Insight 2025" report provides comprehensive insights about 90+ companies and 90+ pipeline drugs in Crohn's Disease pipeline landscape. It covers the…
Acute Pain Clinical Trials Appears Robust With 25+ Key Pharma Companies Actively …
DelveInsight's, "Acute Pain Pipeline Insight 2025" report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Acute Pain pipeline landscape. It covers the…
Metastatic Castration-Resistant Prostate Cancer (mCRPC) Market: Epidemiology, Th …
Metastatic Castration-Resistant Prostate Cancer (mCRPC) therapies, such as JEVTANA (Cabazitaxel), XOFIGO (radium-223), Opevesostat (MK-5684; ODM-208), TRUQAP (capivasertib, AZD 5363), and others, are expected to boost…
Mydriasis Market: Epidemiology, Therapies, Companies, DelveInsight | Théa Labo …
Mydriasis therapies, such as RYZUMVI (Phentolamine Ophthalmic Solution 0.75%), MYDCOMBI, OMIDRIA, and others, are expected to boost the Mydriasis Market in the upcoming years.
DelveInsight has…
Immune Thrombocytopenic Purpura Pipeline 2025: Groundbreaking Clinical Advanceme …
With Immune Thrombocytopenic Purpura reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a…
Focal Segmental Glomerulosclerosis Market: Epidemiology, Therapies, Companies, D …
Focal Segmental Glomerulosclerosis therapies, such as LEQVIO (Inclisiran), Olpasiran (AMG 890), and others, are expected to boost the Focal Segmental Glomerulosclerosis Market in the upcoming…
Merkel Cell Carcinoma Market: Epidemiology, Therapies, Companies, DelveInsight | …
Merkel Cell Carcinoma therapies, such as Pembrolizumab (MK-3475), ITI-3000, Retifanlimab, KRT-232, Nivolumab, Avelumab, atezolizumab,, and others, are expected to boost the Merkel Cell Carcinoma Market…
Spinal Cord Injury Therapeutics Market Size in 7MM is expected to grow at a dece …
DelveInsight's "Spinal Cord Injury Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of SCI, historical and forecasted epidemiology, as well…
Interleukin-2 Clinical Trials Appears Robust With 8+ Key Pharma Companies Active …
DelveInsight's, "Interleukin-2 (IL-2) Inhibitor Pipeline Insight, 2025" report provides comprehensive insights about 8+ companies and 10 pipeline drugs in Interleukin-2 (IL-2) Inhibitor pipeline landscape. It…
Ocular Melanoma Therapeutics Market Size in 7MM is expected to grow at a decent …
DelveInsight's latest report, "Ocular Melanoma Market Insight, Epidemiology And Market Forecast - 2034", combines robust epidemiological data with ocular melanoma market trends, competitive landscape analysis,…
Parainfluenza Virus Infection Therapeutics Market Size in 7MM is expected to gro …
DelveInsight's "Parainfluenza Virus Infection Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Parainfluenza Virus Infection, historical and forecasted epidemiology as…
Postherpetic Neuralgia Therapeutics Market Size in 7MM is expected to grow at a …
(Albany, USA) DelveInsight's "Postherpetic Neuralgia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Postherpetic Neuralgia, historical and forecasted epidemiology as…
ER+/ HER2 -ve Breast Cancer Clinical Trials Appears Robust With 20+ Key Pharma C …
DelveInsight's, "ER positive, HER2 negative Breast Cancer Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in ER positive, HER2…
Mastocytosis Clinical Trials Appears Robust With 10+ Key Pharma Companies Active …
DelveInsight's, "Mastocytosis Pipeline Insight 2025" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Mastocytosis pipeline landscape. It covers the Mastocytosis pipeline…
Hidradenitis Suppurativa Clinical Trials Appears Robust With 24+ Key Pharma Comp …
DelveInsight's, "Hidradenitis Suppurativa Pipeline Insight 2025" report provides comprehensive insights about 24+ companies and 24+ pipeline drugs in Hidradenitis Suppurativa pipeline landscape. It covers the…
Cutaneous Squamous Cell Carcinoma Clinical Trials Appears Robust With 45+ Key Ph …
DelveInsight's, "Cutaneous Squamous Cell Carcinoma Pipeline Insight 2025" report provides comprehensive insights about 45+ companies and 45+ pipeline drugs in Cutaneous Squamous Cell Carcinoma pipeline…
Cutaneous Lupus Erythematosus Clinical Trials Appears Robust With 10+ Key Pharma …
DelveInsight's, "Cutaneous Lupus Erythematosus Pipeline Insight 2025" report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Cutaneous Lupus Erythematosus pipeline landscape. It…
Nephrotic Syndrome Treatment Market Size in the 7MM is expected to increase at a …
DelveInsight's "Nephrotic Syndrome Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Nephrotic Syndrome, historical and forecasted epidemiology, and the Nephrotic…
Mild Cognitive Impairment Treatment Market Size of the 7MM was ~USD 2,836 millio …
DelveInsight's "Mild Cognitive Impairment Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Mild Cognitive Impairment, historical and forecasted…
Intermediate AMD Therapeutics Market Size in the 7MM was ~USD 990 million in 202 …
(openPR) - DelveInsight's "Intermediate AMD Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of intermediate AMD, historical and forecasted epidemiology…
Intermediate AMD Therapeutics Market Size in the 7MM was ~USD 990 million in 202 …
DelveInsight's "Intermediate AMD Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of intermediate AMD, historical and forecasted epidemiology as well…
Hypophosphatasia Therapeutics Market Size in the 7MM was ~USD 997 million in 202 …
DelveInsight's "Hypophosphatasia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Hypophosphatasia, historical and forecasted epidemiology as well as the Hypophosphatasia…
Glioblastoma Multiforme Market Size in the 7MM was ~USD 835 million in 2023 and …
DelveInsight's "Glioblastoma Multiforme Market Insight, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of GBM, historical and forecasted epidemiology as well as the GBM…
Dry AMD Treatment Market Size in 7MM is expected to grow at a decent CAGR by 203 …
DelveInsight's "Dry AMD Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Dry AMD, historical and forecasted epidemiology as well as…
Chronic Kidney Disease Market: Epidemiology, Therapies, Companies, DelveInsight …
Chronic Kidney Disease therapies, such as Ocedurenone (KBP-5074), BI 690517 + Empagliflozin, and others, are expected to boost the Chronic Kidney Disease Market in the…
Cervical Cancer Market: Epidemiology, Therapies, Companies, DelveInsight | ADC t …
Cervical Cancer therapies, such as Volrustomig, PRGN-2009, and others, are expected to boost the Cervical Cancer Market in the upcoming years.
DelveInsight has launched a new…
Axial spondyloarthritis Market: Epidemiology, Therapies, Companies, DelveInsight …
Axial spondyloarthritis therapies, such as SIMPONI (golimumab), XELJANZ (tofacitinib), CIMZIA (certolizumab pegol), ENBREL (Etanercept), RINVOQ (Upadacitinib), COSENTYX (secukinumab), TALTZ (Ixekizumab), LUMICEF (brodalumab), BIMZELX (bimekizumab), and…
Atypical Hemolytic Uremic Syndrome Market: Epidemiology, Therapies, Companies, D …
Atypical Hemolytic Uremic Syndrome therapies, such as Crovalimab (RG6107; SKY59), FABHALTA (iptacopan), and others, are expected to boost the Atypical Hemolytic Uremic Syndrome Market in…
Amyotrophic Lateral Sclerosis Market: Epidemiology, Therapies, Companies, DelveI …
Amyotrophic Lateral Sclerosis therapies, such as Masitinib, NurOwn (MSC-NTF cells), and others, are expected to boost the Amyotrophic Lateral Sclerosis Market in the upcoming years.
DelveInsight…
Go To Page: 1 2 3 4 5 6 7 8 9 10 51 52 53 54 55 56 57 58 59 60
